None listed
Conditions
Brief summary
The study will let us explore the role of insulin pump therapy for adolescent with type 1 diabetes and poor control. These patients are often excluded from accessing this therapeutic tools due to concerns regarding safety, or because a lack of financial support. We will look at many outcomes including glycaemic control, episodes of diabetic ketoacidosis and severe hypoglycaemia, as well general quality of life and psychosocial functioning.
Interventions
In this pilot interventional study, we will study patients with type 1 diabetes. They will recieve a 6 week education package on diabetes control and how to use an insulin pump. The education package will consisit of 4 x 2hour one on one sessions, three of which are with a diabetes nurse educator, and one with a dietician. The four sessions will be spread over 6 weeks and will occur at times that are convenient to the participant and health practitioner. They will be then started on an insulin p
In this pilot interventional study, we will study patients with type 1 diabetes. They will recieve a 6 week education package on diabetes control and how to use an insulin pump. The education package will consisit of 4 x 2hour one on one sessions, three of which are with a diabetes nurse educator, and one with a dietician. The four sessions will be spread over 6 weeks and will occur at times that are convenient to the participant and health practitioner. They will be then started on an insulin pump and followed up for a period of 12 months. We will use the Medtronic Veo insulin pump. This device delivers insulin in two ways: background basal insulin as a slow sub cutaneous infusion, and as bolus ammounts for carbohydrate that is eaten or to correct high blood glucose. The background basal rates and insulin bolus amounts are unique for each patient and are calculated by the team at pump start. Participant compliance and progress will be monitored in their usual diabetes outpatient clinic by the paediatric endocrinologist.
Sponsors
Martin de Bock
Study design
Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
14 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
1. Age 14 - 18 years with type 1 diabetes 2. Duration of diabetes at least 12 months 3. Insulin pump therapy naive 4. HbA1C>10% for the preceding 6 months
Exclusion criteria
1. Pregnancy 2. Any additional condition(s) that in the investigator’s opinion would warrant exclusion from the study or prevent the subject from completing the study
Outcome results
None listed